Evidence map›Paper›PMID 40784966›Full record

ArticleScientific reports2025

Genome-wide CRISPR screen for human factors involved in alternative polyadenylation based on differential localization of CD47.

Chayanin Wuttinontananchai, Junichi Yamamoto, Satoshi Sakamoto, Yuki Yamaguchi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chayanin WuttinontananchaiSchool of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan.
Junichi YamamotoSchool of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan.
Satoshi SakamotoSchool of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan.
Yuki YamaguchiSchool of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan. yamaguchi.y.8072@m.isct.ac.jp.

Funding

Japan Society for the Promotion of Science 20H03182Japan Society for the Promotion of Science 23K07807
6 · The paper itself

Abstract

At least 70% of the human protein-coding genes contain multiple polyadenylation sites (PAS) and undergo alternative polyadenylation (APA), generating distinct transcripts from a single gene. While APA has been implicated in various physiological and pathological processes, its regulatory factors and cellular mechanisms remain incompletely understood. A previous study demonstrated that APA influences the localization of the cell surface marker CD47. Here, we present the results of a genome-wide CRISPR screen aimed at identifying APA regulators using CD47 as a reporter. Given that isoform-specific knockdown of CD47, as well as knockdown of core 3' end processing factors, alters CD47 localization, we developed an immunofluorescence-based method that simultaneously detects cell surface and intracellular CD47 protein, enabling the visualization of APA-dependent changes at the single-cell level. Leveraging this approach, we conducted a CRISPR screen and identified multiple genes affecting CD47 cell-surface expression. In addition to known membrane trafficking factors, we uncovered several nuclear factors, among which POLDIP2 emerged as a potential novel APA regulator with a global impact on APA. This study provides a foundation for further investigations into the molecular mechanisms governing APA.

Indexed as

CD47 AntigenClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsPolyadenylationGenome, HumanHEK293 CellsHumansCD47 AntigenCD47 protein, humanAlternative polyadenylationCD47Genome-wide CRISPR screenPOLDIP2RNA-seq

Identifiers

PMID40784966
PMCPMC12336307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.